当前位置:首页 - 行情中心 - 鲁抗医药(600789) - 财务分析 - 现金流量表

鲁抗医药

(600789)

  

流通市值:72.03亿  总市值:74.52亿
流通股本:10.10亿   总股本:10.45亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,815,053,548.032,575,466,803.11,268,662,185.395,116,633,874.44
  收到的税费返还34,097,839.8119,613,930.1517,636,848.4634,497,737.23
  收到其他与经营活动有关的现金89,674,144.2255,367,249.5327,256,147119,255,037.06
  经营活动现金流入小计3,938,825,532.062,650,447,982.781,313,555,180.855,270,386,648.73
  购买商品、接受劳务支付的现金2,819,371,485.841,659,186,581.59822,357,277.983,039,220,239.75
  支付给职工以及为职工支付的现金549,434,340.83365,270,307.94189,944,925.81737,756,843.62
  支付的各项税费135,517,470.5588,559,682.3234,817,077.6188,908,016.59
  支付其他与经营活动有关的现金299,736,837.26178,631,755.68102,312,820.15606,327,699.75
  经营活动现金流出小计3,804,060,134.482,291,648,327.531,149,432,101.544,572,212,799.71
  经营活动产生的现金流量净额134,765,397.58358,799,655.25164,123,079.31698,173,849.02
二、投资活动产生的现金流量:
  收回投资收到的现金---1,189,693.63
  处置固定资产、无形资产和其他长期资产收回的现金净额18,892,285.3618,812,647.7118,812,647.71104,201,617.59
  投资活动现金流入小计18,892,285.3618,812,647.7118,812,647.71105,391,311.22
  购建固定资产、无形资产和其他长期资产支付的现金236,229,594.97163,016,645.5538,303,519.16338,862,954.47
  投资支付的现金1,161,3601,161,360--
  投资活动现金流出小计237,390,954.97164,178,005.5538,303,519.16338,862,954.47
  投资活动产生的现金流量净额-218,498,669.61-145,365,357.84-19,490,871.45-233,471,643.25
三、筹资活动产生的现金流量:
  吸收投资收到的现金---1,186,829,138.68
  取得借款收到的现金823,301,300405,055,500349,547,5001,875,320,580.49
  收到其他与筹资活动有关的现金---100,000,000
  筹资活动现金流入小计823,301,300405,055,500349,547,5003,162,149,719.17
  偿还债务支付的现金1,478,025,702.351,012,455,702.35699,388,658.241,639,338,422.23
  分配股利、利润或偿付利息支付的现金92,431,246.0524,924,826.2511,969,449.85167,300,555.68
  其中:子公司支付给少数股东的股利、利润---1,002,800
  支付其他与筹资活动有关的现金679,245.28679,245.28679,245.28200,000,000
  筹资活动现金流出小计1,571,136,193.681,038,059,773.88712,037,353.372,006,638,977.91
  筹资活动产生的现金流量净额-747,834,893.68-633,004,273.88-362,489,853.371,155,510,741.26
四、汇率变动对现金及现金等价物的影响-11,518,905.62-8,523,397.07-5,283,354.812,244,815.3
五、现金及现金等价物净增加额-843,087,071.33-428,093,373.54-223,141,000.321,622,457,762.33
  加:期初现金及现金等价物余额2,118,158,954.32,118,158,954.32,118,158,954.3495,701,191.97
  期末现金及现金等价物余额1,275,071,882.971,690,065,580.761,895,017,953.982,118,158,954.3
补充资料:
  净利润-145,987,096.15-111,906,367.03
  资产减值准备-23,751,147.07-45,731,523.35
  固定资产和投资性房地产折旧-194,280,555.06-384,169,213.68
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-194,280,555.06-384,169,213.68
  无形资产摊销-26,313,218.58-64,898,995.97
  长期待摊费用摊销-311,878.32-471,364.08
  处置固定资产、无形资产和其他长期资产的损失--1,946.9--168,153.08
  固定资产报废损失-238,140.89-179,201.08
  公允价值变动损失-0-71,340
  财务费用-42,944,873.1-63,541,194.82
  投资损失-2,801,782.35-5,220,411.67
  递延所得税--2,074,120.8--16,491,379.72
  其中:递延所得税资产减少--2,074,120.8--16,491,379.72
    递延所得税负债增加-0--
  存货的减少--86,909,616.84-191,085,798.16
  经营性应收项目的减少--158,680,403.4-169,326,364.6
  经营性应付项目的增加-154,579,264.29--331,301,202.67
  其他---3,349,708.54
  现金的期末余额-1,690,065,580.76-2,118,158,954.3
  减:现金的期初余额-2,118,158,954.3-495,701,191.97
  现金及现金等价物的净增加额--428,093,373.54-1,622,457,762.33
公告日期2026-10-292026-08-292026-04-252026-04-25
审计意见(境内)标准无保留意见
TOP↑